Ваша жизнь в ваших руках. Как понять, победить и предотвратить рак груди и яичников - Джейн Плант (2012)

39. Fisher, B., Bryant, J., Dignam, J.J., Wickerham, D.L., Mamou-nas, E.F., Fisher, E.R., Margolese, KG., Nesbitt, L., Paik, S., Pisansky, T.M., Wolmark, N., 2002. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less./ Clin Oncol, 20 (20), 4141–4149; www.ncbi.nlm.nih.gov; 80

40. Fisher, B., Anderson, S., Bryant, J., Margolese, R.G., Deutsch, M., Fisher, E.R., Jeong, J.H. and Wolmark, N., 2002. Twenty-year follow-up of a randomised trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med, 347 (16), 1233–1241; www.ncbi.nlm.nih.gov; 80

41. Gottlieb, Scott. Lumpectomy is as effective as mastectomy for breast cancer. BMJ, 325, 921.

42. www.nlm.nih.gov/medlineplus/ency/article/002919.htm

43. www.nlm.nih.gov/medlineplus/ency/article/002919. htm

44. www.cancer.org/docroot/cri/content/cri_2_6x_breast_recon-struction_after_mastectomy_5.asp

45. Bartelinkh and others, 2001. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. New England J Med, 345 (19), 1378–1387.

46.

47. Morrow, Monica and Gradishar, William, 2002. Recent Development: Breast Cancer. BMJ, 324, 410–414.

48. Coombes, R.C. and others, 2006. American Society of Clinical Oncology, Annual Meeting, Atlanta Georgia, June 2006.

49. Gralow, Julie R., 2002. Bisphosphonates as adjuvant treatment for breast cancer. BMJ, 325, 1051–1052.

50. www.gene.com/gene/products/information/oncology/ herceptin;

www.herceptin.com/herceptin/ physician/pi.htm

51. www.herceptin.com/herceptin/physician/pi.htm

52. Anon, 2006. Patient is to appeal High Court ruling on breast cancer drug. BMJ, 332–443.

53. Barrett, A. and others, 2006. How much will herceptin really cost? BMJ, 333, 1118–1120.

54. Daily Mail, Monday, 9 October, 2006.

55. www.ahrq.gOv/news/press/pr2002/brchempr.htm

56. 16.htm

56. 7_16. htm

57. Gottlieb, Scott, 2002. Tamoxifen may increase risk of uterine sarcoma, BMJ, 325, 7.

58. htm

59. Mayor, Susan, 2002. Anastrozole shows promise for early breast cancer. BMJ, 324, 1539

60. www.gene.com/gene/products/information/oncology/hercep-tin;

www.herceptin.com/herceptin/physician/pi.htm

61. htm

62. www.ahrq.gov/news/press/pr2002/brchempr.htm

63. New Scientist, 20 January, 2007.

64. Editorial, New Scientist, 31 March, 2007.

65. Josefson, Deborah, 2002. Doctors warned to be wary of new drugs. BMJ, 324, 1113.

66. Garattini, Silvio and Bertele, Vittorio, 2002. Efficacy, safety, and cost of new anticancer drugs. BMJ, 325, 269–271.

67. www.cancer.gov

68. Modified after: Chemotherapy and You: A Guide to Self-Help During Cancer Treatment. Information about what to expect during chemotherapy and what patients can do to take care of themselves during and after treatment NIH Publication #99-1136: www.cancer.gov/cancerinfo/chemorherapy-and-you

69. Smith, I. and Chue, S., 2006. Medical treatment of early breast cancer. BMJ, 332, 162–181.

70. Allison, R. and others, 2006.Photodiagnosis and photodynamic therapy, 3, 139–146.

71. Fritsch, С. and Ruzika, Т., 2003. Fluorescence diagnosis and photodynamic therapy of skin diseases atlas and handbook. Vien: Springer-Verlag.

72. Coulter; Angela, 2003. Killing the goose that laid the golden egg. BMJ, 326, 1280.

73. Coulter, Angela, 2003. Killing the goose that laid the golden egg. BMJ, 326, 1280.

74. Ernst, E., 2003. Herbal medicines put into context. BMJ, 327, 881–882.